UCLA Journal of Radiation Oncology APRIL 2023 - Flipbook - Page 18
UCLA RADIATION ONCOLOGY JOURNAL
Randomized Clinical Trial. JAMA Oncol 2023 (In eng). DOI:
imaging-guided versus computed tomography-guided
10.1001/jamaoncol.2022.6558.
stereotactic body radiotherapy for prostate cancer (MIRAGE):
Interim analysis of a phase III randomized trial. Journal of
6 Schaeffer E, Srinivas S, Antonarakis ES, et al. NCCN
Clinical Oncology 2022;40(6_suppl):255-255. DOI: 10.1200/
Guidelines Insights: Prostate Cancer, Version 1.2021. J Natl
JCO.2022.40.6_suppl.255.
Compr Canc Netw 2021;19(2):134-143. (In eng). DOI: 10.6004/
jnccn.2021.0008.
Reprinted with permssion from The Cancer Letter.
7 Antolak JA, Rosen, II. Planning target volumes for
Originally printed on February 03, 2023 in Vol.49, No.05 of The
radiotherapy: how much margin is needed? Int J Radiat Oncol
Cancer Letter.
Biol Phys 1999;44(5):1165-70. (In eng). DOI: 10.1016/s03603016(99)00117-0.
8 Levin-Epstein R, Qiao-Guan G, Juarez JE, et al. Clinical
Assessment of Prostate Displacement and Planning Target
Volume Margins for Stereotactic Body Radiotherapy of Prostate
Cancer. Front Oncol 2020;10:539. (In eng). DOI: 10.3389/
fonc.2020.00539.
9 Soni PD, Hartman HE, Dess RT, et al. Comparison of
Population-Based Observational Studies With Randomized Trials
in Oncology. J Clin Oncol 2019;37(14):1209-1216. (In eng). DOI:
10.1200/jco.18.01074.
10 Zelefsky MJ, Kollmeier M, McBride S, et al. FiveYear Outcomes of a Phase 1 Dose-Escalation Study Using
Stereotactic Body Radiosurgery for Patients With Low-Risk and
Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys
2019;104(1):42-49. (In eng). DOI: 10.1016/j.ijrobp.2018.12.045.
11 Levin-Epstein RG, Jiang NY, Wang X, et al. Dose-response
with stereotactic body radiotherapy for prostate cancer: A
multi-institutional analysis of prostate-specific antigen kinetics
and biochemical control. Radiother Oncol 2021;154:207-213. (In
eng). DOI: 10.1016/j.radonc.2020.09.053.
12 Kishan AU, Wang X, Sun Y, et al. High-dose Radiotherapy
or Androgen Deprivation Therapy (HEAT) as Treatment
Intensification for Localized Prostate Cancer: An Individual
Patient-data Network Meta-analysis from the MARCAP
Consortium. Eur Urol 2022;82(1):106-114. (In eng). DOI:
10.1016/j.eururo.2022.04.003.
13 Rodda S, Tyldesley S, Morris WJ, et al. ASCENDE-RT: An
Analysis of Treatment-Related Morbidity for a Randomized Trial
Comparing a Low-Dose-Rate Brachytherapy Boost with a DoseEscalated External Beam Boost for High- and Intermediate-Risk
Prostate Cancer. Int J Radiat Oncol Biol Phys 2017;98(2):286-295.
(In eng). DOI: 10.1016/j.ijrobp.2017.01.008.
14 Kishan AU, Lamb J, Casado M, et al. Magnetic resonance
18
Featured on nearly 100 news
outlets, including ASCO Post,
Medscape, and OncLive.
Additionally, Dr. Kishan has been
invited on multiple podcasts and
interviews to discuss this research
and promote UCLA Radiation
Oncology's program.